{"disease":{"id":"haematological-malignancies","name":"haematological malignancies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05148806","title":"Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies","phase":"","overall_status":"COMPLETED","enrollment_count":28411,"lead_sponsor_name":"Imperial College London","has_results":true},{"nct_id":"NCT06829654","title":"Cryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological Tumors","phase":"NA","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT04865419","title":"Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":46,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT03263637","title":"Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04630756","title":"AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT06797037","title":"Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Patients Receiving Oral Treatment for Cancer or Malignant Haemopathy (ACCELER PLATFORM)","phase":"NA","overall_status":"RECRUITING","enrollment_count":33,"lead_sponsor_name":"Institut Claudius Regaud","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}